Home › Chest Injuries and Disorders › NCT07485829
Zimmer Biomet-RibFix Titan
Zimmer Biomet Patient Outcomes and Experience After Chest Wall Repair With RibFix Titan™
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. At least 18 years of age 2. Willing and able to sign an Institutional Review Board (IRB) approved Informed Consent Form and able to comply with study requirements, in the Investigator's opinion 3. Independent of study participation, patient qualifies for fixation, stabilization, and/or fusion of rib fractures or osteotomies of normal and osteoporotic bone with the study device Exclusion Criteria: 1. Midline Sternotomy: sternotomy incisions crossing the midline 2. Active Infection: patients should not have any ongoing infections 3. Material Sensitivity: where sensitivity to materials is suspected, comprehensive testing should be conducted before implantation 4. Inability to Adhere to Post-operative Care: Patients must have the ability and willingness to comply with post-operative care instructions, which may not be possible for individuals with certain mental or neurological conditions 5. Patients not expected to survive the duration of follow-up due to the involvement of trauma situations 6. Patients with a history of alcohol or substance abuse, as well as vulnerable populations such as prisoners and pregnant women
About the study
Prospective, single-center, non-randomized, single-cohort, post-market clinical follow-up study to confirm the safety, performance, and clinical benefits for the use of the RibFix Titan™ system implants and instrumentation) in the fusion, stabilization, and fixation of fractures in the chest wall including rib reconstructive surgical procedures, trauma, or planned osteotomies.
What is being tested
- The RibFix Titan™ device should be used within this arm of the study. (device)
Sponsor: Zimmer Biomet · Participants: 54 · Started: Mar 31, 2026
Contact the study team
- Megan McKinnie · Phone: (919)381-7091
- Lynsey Boyle · Phone: (412)552-7111
Official record on ClinicalTrials.gov — NCT07485829
Locations in the U.S.
| Indiana | Ascension St. Vincent Hospital, Indianapolis |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.